医学
改良兰金量表
冲程(发动机)
随机对照试验
急性中风
纳入和排除标准
闭塞
临床试验
外科
缺血性中风
内科学
缺血
组织纤溶酶原激活剂
替代医学
病理
工程类
机械工程
作者
Shashvat M. Desai,Diogo C Haussen,Amin Aghaebrahim,Alhamza R Al‐Bayati,Roberta Santos,Raul G. Nogueira,Tudor G. Jovin,Ashutosh P. Jadhav
标识
DOI:10.1136/neurintsurg-2018-013923
摘要
Thrombectomy appears to be safe and feasible in patients with acute ischemic stroke due to LVO meeting all DAWN trial criteria but treated beyond 24 hours of TLKW with outcomes comparable to patients in the DAWN trial intervention arm. Further studies are warranted to validate these findings.
科研通智能强力驱动
Strongly Powered by AbleSci AI